LANXESS IS NO GERMAN ARKEMA QUITE YET (REDUCE; +8% UPSIDE)
01/10/24 -" Lanxess’ (Reduce; Germany) equity story is a difficult one. At first sight, the company seems to have the portfolio rotation gene, but there is hardly any positive effect to be identified. Lanxess ..."
Pages
61
Language
English
Published on
01/10/24
You may also be interested by these reports :
03/06/26
K+S announced the acquisition of the salts business from Qemetica for €350m, plus a potential €30m earn-out. While the deal values the assets at ...
28/05/26
H2 2025/26 remained a mixed bag for JMAT, with weak demand and metal losses weighing on Clean Air and PGM Services. EBIT remained dependent on cost ...
27/05/26
Akzo Nobel rejected a €13bn bid from Nippon Paint and Sherwin-Williams, despite the offer implying a 39% premium to its share price. Positive ...
20/05/26
2026/2027: EPS increase is driven by a strong Q1 2026 underpinning management expectations of €1.0bn in 2026 EBITDA. We remain optimistic on earnings ...